These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29552643)

  • 1. Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort study.
    Thielemans L; Gornsawun G; Hanboonkunupakarn B; Paw MK; Porn P; Moo PK; Van Overmeire B; Proux S; Nosten F; McGready R; Carrara VI; Bancone G
    Wellcome Open Res; 2018; 3():1. PubMed ID: 29552643
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification to reporting of qualitative fluorescent spot test results improves detection of glucose-6-phosphate dehydrogenase (G6PD)-deficient heterozygote female newborns.
    Nadarajan V; Shanmugam H; Sthaneshwar P; Jayaranee S; Sultan KS; Ang C; Arumugam S
    Int J Lab Hematol; 2011 Oct; 33(5):463-70. PubMed ID: 21501392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of G6PD deficiency in Thai blood donors, the characteristics of G6PD deficient blood, and the efficacy of fluorescent spot test to screen for G6PD deficiency in a hospital blood bank setting.
    Rojphoung P; Rungroung T; Siriboonrit U; Vejbaesya S; Permpikul P; Kittivorapart J
    Hematology; 2022 Dec; 27(1):208-213. PubMed ID: 35134307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells.
    Baird JK; Dewi M; Subekti D; Elyazar I; Satyagraha AW
    Transl Res; 2015 Jun; 165(6):677-88. PubMed ID: 25312015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why does the Iranian national program of screening newborns for G6PD enzyme deficiency miss a large number of affected infants?
    Kosaryan M; Mahdavi MR; Jalali H; Roshan P
    Pediatr Hematol Oncol; 2014 Feb; 31(1):95-100. PubMed ID: 24483842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period.
    Keihanian F; Basirjafari S; Darbandi B; Saeidinia A; Jafroodi M; Sharafi R; Shakiba M
    Int J Lab Hematol; 2017 Jun; 39(3):251-260. PubMed ID: 28258653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.
    Henriques G; Phommasone K; Tripura R; Peto TJ; Raut S; Snethlage C; Sambo I; Sanann N; Nguon C; Adhikari B; Pongvongsa T; Imwong M; von Seidlein L; Day NP; White NJ; Dondorp AM; Newton P; Ley B; Mayxay M
    Malar J; 2018 Jun; 17(1):243. PubMed ID: 29929514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of neonatal reticulocytosis on glucose 6-phosphate dehydrogenase (G6PD) activity and G6PD deficiency detection: a cross-sectional study.
    Pimpakan T; Mungkalasut P; Tansakul P; Chanda M; Jugnam-Ang W; Charucharana S; Cheepsunthorn P; Fucharoen S; Punnahitananda S; Cheepsunthorn CL
    BMC Pediatr; 2022 Nov; 22(1):678. PubMed ID: 36419023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of detection of glucose-6-phosphate dehydrogenase deficiency using fluorescent spot test, enzyme assay and molecular method for prediction of severe neonatal hyperbilirubinaemia.
    Wang FL; Boo NY; Ainoon O; Wong MK
    Singapore Med J; 2009 Jan; 50(1):62-7. PubMed ID: 19224086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the fluorescence spot test for neonatal screening of G6PD deficiency.
    Jiang J; Ma X; Song C; Lin B; Cao W; Wu S; Hsiao KJ
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():140-2. PubMed ID: 15906719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.
    Roca-Feltrer A; Khim N; Kim S; Chy S; Canier L; Kerleguer A; Tor P; Chuor CM; Kheng S; Siv S; Kachur PS; Taylor WR; Hwang J; Menard D
    PLoS One; 2014; 9(12):e116143. PubMed ID: 25541721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.
    Oo NN; Bancone G; Maw LZ; Chowwiwat N; Bansil P; Domingo GJ; Htun MM; Thant KZ; Htut Y; Nosten F
    PLoS One; 2016; 11(4):e0152304. PubMed ID: 27035821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical evaluation and usability of a quantitative G6PD POC test in cord blood: a mixed-methods study in a low-resource setting.
    Bancone G; Gilder ME; Win E; Gornsawun G; Penpitchaporn P; Moo PK; Archasuksan L; Wai NS; Win S; Aung KK; Hashmi A; Hanboonkunupakarn B; Nosten F; Carrara VI; McGready R
    BMJ Open; 2022 Dec; 12(12):e066529. PubMed ID: 36523222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency at the China-Myanmar Border.
    Li Q; Yang F; Liu R; Luo L; Yang Y; Zhang L; Liu H; Zhang W; Fan Z; Yang Z; Cui L; He Y
    PLoS One; 2015; 10(7):e0134593. PubMed ID: 26226515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalences of inherited red blood cell disorders in pregnant women of different ethnicities living along the Thailand-Myanmar border.
    Bancone G; Gilder ME; Chowwiwat N; Gornsawun G; Win E; Cho WW; Moo E; Min AM; Charunwatthana P; Carrara VI; White NJ; Nosten F; McGready R
    Wellcome Open Res; 2017; 2():72. PubMed ID: 29181452
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.
    Satyagraha AW; Sadhewa A; Elvira R; Elyazar I; Feriandika D; Antonjaya U; Oyong D; Subekti D; Rozi IE; Domingo GJ; Harahap AR; Baird JK
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004457. PubMed ID: 26894297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluations of newborn screening program performance and enzymatic diagnosis of glucose-6-phosphate dehydrogenase deficiency in Guangzhou].
    Tang F; Huang YL; Jiang X; Jia XF; Li B; Feng Y; Chen QY; Tang CF
    Zhonghua Er Ke Za Zhi; 2018 May; 56(5):359-363. PubMed ID: 29783822
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
    Pal S; Bansil P; Bancone G; Hrutkay S; Kahn M; Gornsawun G; Penpitchaporn P; Chu CS; Nosten F; Domingo GJ
    Am J Trop Med Hyg; 2019 Jan; 100(1):213-221. PubMed ID: 30350771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the Inherited Glucose-6-phosphate Dehydrogenase Deficiency on the Appearance of Neonatal Hyperbilirubinemia in Southern Croatia.
    Cherepnalkovski AP; Marusic E; Piperkova K; Lozic B; Skelin A; Gruev T; Krzelj V
    Acta Inform Med; 2015 Oct; 23(5):264-7. PubMed ID: 26635431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semiquantitative screening test for G6PD deficiency detects severe deficiency but misses a substantial proportion of partially-deficient females.
    Ainoon O; Alawiyah A; Yu YH; Cheong SK; Hamidah NH; Boo NY; Zaleha M
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):405-14. PubMed ID: 12971572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.